Congress

In this section you will find, listed in chronological order, international congresses in which we intended or we plan to go. These congresses allow us to present our research results to the scientific community through poster or oral communications. They also allow us to establish contacts with various people involved in research on fibrosis, for example in human medicine or in the pharmaceutical field.

2016

21 October 2016, FARAH day, ULg, Belgique
3rd “Fundamuntal and Applied Research for Animal and Health” day

Compartive analysis of the respiratory microbiota of healthy dogs and dogs with canine idiopathic pulmonary fibrosis E. Roels, B. Taminiau, E. Darnis, F. Neveu, G. Daube and C. Clercx

8 – 10 September 2016, Goteborg, Sweden
26th ECVIM-CA Congress
www.ecvimcongress.org

Comparative analysisof the respiratory microbiota of healthy dogs and dogs with canine idiopathic pulmonary fibrosis
E. Roels; B. Taminiaux; E. Darnis; F. Neveu; G. Daube; C. Clercx

Diagnostic value of PV/PA ratio in dogs with PH of pre-capillary origin
E. Roels; A.C. Merveille; P.L. Malaize; C. Clercx; K. Mc Entee

Investigation of the coagulation system in canine idiopathic pulmonary fibrosis
E. Roels; N. Bauer; C. Lecut; F. Billen; C. Soete; P. Peters; A. Moritz; A. Gothot; C. Clercx

2015

16 October 2015, FARAH day, ULg, Belgique
2nd “Fundamuntal and Applied Research for Animal and Health” day

Standardized characterization of thoracic HRCT findings in West Highland white terriers with canine idiopathic pulmonary fibrosis: Effect of sedation vs. anaesthesia in healthy and diseased dogs E. Roels, T. Couvreur, C. Clercx J. Verschakelen and G. Bolen

08 – 10 October 2015, Edinburgh, Scotland
33rd annual symposium of the Veterinary Comparative Respiratory Society (VCRS)
www.the-vcrs.org

Canine idiopathic pulmonary fibrosis is not associated with herpesvirus infection
E. Roels; M. Dourcy; S. Holopainen; M.M. Rajamäki; L. Gillet; C. Clercx

Standardized characterization of thoracic high-resolution computed tomographic findings in West Highland white terriers with canine idiopathic pulmonary fibrosis:
Effect of sedation vs. anesthesia in healthy and affected dogs
E. Roels; T. Couvreur; C. Soete; C. Clercx; J. Verschakelen; G. Bolen

10 – 12 September 2015, Lisboa, Portugal
25th ECVIM-CA Congress
www.ecvimcongress.org

Chemokine (CC-motif) ligand 2 as a prognostic serum marker in canine idiopathic pulmonary fibrosis
E. Roels; S. Holopainen; E. Teske; CIPF European Consortium; M.M. Rajamäki; C. Clercx

2014

17 October 2014, FARAH day, ULg, Belgique
1th “Fundamuntal and Applied Research for Animal and Health” day

Vascular endothelial growth factor : a blood biomarker in canine idiopathic pulmonary fibrosis?
E. Roels, E. Krafft, H.P. Laurila, M.M. Rajamäki and C. Clercx

20 – 24 September 2014, Mont-Tremblant, Quebec, Canada
18th international colloquium on lung and airways fibrosis (ICLAF)
www.iclaf.com

Is 5-Hydroxytryptamine (serotonin) Involved in the Pathogeneis of Canine Idiopathic Pulmonary Fibrosis
E. Krafft; E. Roels; H.P. Laurila; M.M. Rajamäki; F. Farnir; N. Antoine; C. Clercx

BALF and Serum Levels of CCL2 and CXCL8 Chemokines in Canine Idiopathic Pulmonary Fibrosis
E. Roels; E. Krafft; N. Antoine; F. Farnir; H.P. Laurila; M.M. Rajamäki; C. Clercx

Evaluation of TGF-beta1, 5-HT, CCL2 and CXCL8 Blood Levels In Healthy Dogs from Seven Breeds Differently Predisposed to Canine Idiopathic Pulmonary Fibrosis
E. Roels; E. Krafft; N. Antoine; F. Farnir; H.P. Laurila; M.M. Rajamäki; C. Clercx

4 – 6 September 2014, Rheingoldhalle, Mainz, Germany
24th ECVIM-CA Congress
www.ecvimcongress.org

Clinical and Histopathological Findings in West Highland white terriers with Idiopathic Pulmonary Fibrosis
H.P. Heikkilä-Laurila

Role of TGF-beta in the Pathogenesis of Canine Idiopathic Pulmonary Fibrosis
E. Krafft

Biomarkers in Canine Idiopathic Pulmonary Fibrosis (CIPF)
C. Clercx

Right Pulmonary Vein to Pulmonary Artery Ratio: A New Echocardiographic Index of Pulmonary Hypertension in West Highland white terriers with Idiopathic Pulmonary Fibrosis
E. Roels; A.C. Merveille; E. Krafft; F. Farnir; S. Gomart; C. Clercx; K. McEntee

Correlation Betwee, Thoracic CT-scan Angiography Findings and Echicardiographic Right Pulmonary Vein to Pulmonary Artery Ratio in West Highland White terriers with Idiopathic Pulmonary Fibrosis
E. Roels; A.C. Merveille; T. Couvreur; G. Bolen; E. Krafft; C. Clercx; K. McEntee

Vascular Endothelial Growth Factor: A Blood Biomarker in Canine Idiopathic Pulmonary Fibrosis ?
E. Roels; E. Krafft; H.P. Laurila; M.M. Rajamäki; C. Clercx

Activin B, But Not Activin A, Is Upregulated in Lungs of West Highland white terriers with Canine Idiopathic Pulmonary Fibrosis
L.I.O. Lijla-Maula; P. Syrjä; H.P. Laurila; E. Sutinen; M. Palviainen; K. Koli; M.M. Rajamäki; M. Myllärniemi

27 – 29 April 2014, Louisville, Kentucky, USA
Fibrosis across species meeting

Clinical Presentation and Epidemiology of Idiopathic Pulmonary Fibrosis in Domestic Animals: Update on Investigation in CIPF
C. Clercx

2013

12 – 14 September 2013, Livepool, UK
23rd ECVIM-CA Congress

Survival and Prognostic Factors in West Highland White Terriers with Idiopathic Pulmonary Fibrosis
H.P. Laurila; L.I.O. Lilja-Maula; A.K. Lappalainen; P. Syrjä; E. Krafft; C. Clercx; M.M. Rajamäki

Immunohistochemical Analysis of Transforming Growth Factor Beta 1 and Its Signalling Pathways in Canine Idiopathic Pulmonary Fibrosis
E. Krafft; H.P. Laurila; M.M. Rajamäki; M. Myllärniemi; M.J. Day; P. Lybaert; C. Clercx

Is 5-Hydroxytryptamine (Serotonine) Involved in the Pathogenesis of Idiopathic Pulmonary Fibrosis in Dogs?
E. Krafft; E. Roels; HP. Laurila; MM. Rajamäki; F. Farnir; N. Antoine; C. Clercx

Is the CXC-Chemokine CXCL8 Involved in the Breed Predisposition of West Highland White Terrier to Canine Idiopathic Pulmonary Fibrosis?
E. Roels; E. Krafft; H.P. Laurila; M.M. Rajamäki; N. Antoine; M. Massart; C. Clercx

congres-liverpool

Presentation of our research results by Dr. Roels Elodie at the 23rd ECVIM congress

10 – 12 July 2013, Nottingham, UK
20th Annual BALR Summer Meeting: Curing pulmonary fibrosis: The Holy Grail

Transforming Growth Factor Beta 1 and Its Activation, Storage and Signalling Pathways in Canine Idiopathic Pulmonary Fibrosis
E. Krafft, H.P. Laurila, M.M. Rajamäki, M. Myllärniemi, F. Farnir, M.J. Day, P. Lybaert, K. McEntee, C. Clercx

2012

29 September – 3 October 2012, Modena, Italy
17th International Colloquium on Lung & Airway fibrosis
www.iclaf2012.unimore.it

Elevation of Matrix Metalloproteinase -2 and -9 Activities in Bronchoalveolar Lavage Fluid of Dogs with Idiopathic Pulmonary Fibrosis
H.P. Heikkilä, L. Lilja-Maula, E. Krafft, D. De Lorenzi, C. Clercx, M.M. Rajamäki

Gene Expression Profiles In Canine Idiopathic Pulmonary Fibrosis
E. Krafft, H.P. Heikkilä, M.J. Day, I.R. Peters, D. Peeters, M.M. Rajamäki, C. Clercx

6 – 8 September 2012, Maastricht, Netherlands
22nd ECVIM-CA Congress

Transforming Growth Factor-Beta 1 and its Activating Pathways in Canine Idiopathic Pulmonary Fibrosis
E. Krafft; H.P. Heikkilä; M.J. Day; I.R. Peters; K. Mcentee; D. Peeters; M.M. Rajamäki; C. Clercx

CCL2 as a Serum Biomarker of Idiopathic Pulmonary Fibrosis in Dogs
E. Krafft; E. Roels; H.P. Heikkilä; M.J. Day; M.M. Rajamäki; C. Clercx

ECVIM2012

Share.